Clinical Trials Logo

Psoriasis clinical trials

View clinical trials related to Psoriasis.

Filter by:

NCT ID: NCT05427175 Active, not recruiting - Psoriasis Clinical Trials

Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis

Start date: January 10, 2022
Phase: Phase 4
Study type: Interventional

The aim of the study is to evaluate the effect of NB-UVB versus MTX on serum Chitotriosidase level in psoriatic patients.

NCT ID: NCT05415839 Not yet recruiting - Clinical trials for the Efficacy of Fractional Co2 Laser in Nail Psoriais

Fractional CO2 Laser Versus Pulsed Dye Laser in Nail Psoriasis

Start date: June 25, 2022
Phase: N/A
Study type: Interventional

The aim of this work is to assess the efficacy and safety of fractional CO2 laser therapy in comparison to pulsed dye laser (PDL) in the treatment of nail psoriasis.

NCT ID: NCT05408208 Recruiting - Localized Psoriasis Clinical Trials

Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis

Start date: May 21, 2022
Phase: N/A
Study type: Interventional

The aim of the present study is to evaluate the efficacy of intralesional injection of methotrexate in comparison with Intralesional Injection of Triamcinolone Acetonid in localized psoriasis (body surface area < 10%) .

NCT ID: NCT05406908 Completed - Psoriasis Clinical Trials

Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Start date: June 15, 2022
Phase: Phase 4
Study type: Interventional

This is a randomised controlled trial conducted to prove that the immunological performance of intradermal tozinameran (i.e., Pfizer-BioNTech COVID-19 vaccine) is no worse than the standard intramuscular route in patients with immune-mediated dermatologic diseases. The side effects profile and disease activity post-vaccination will also be assessed.

NCT ID: NCT05401006 Active, not recruiting - Psoriasis Clinical Trials

Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .

Start date: June 5, 2021
Phase: Phase 4
Study type: Interventional

To evaluate effect of acitretin versus Narrowband UVB on serum level of neopterin in psoriatic patients.

NCT ID: NCT05399433 Recruiting - Psoriasis Clinical Trials

Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis

Start date: June 30, 2022
Phase: N/A
Study type: Interventional

Dendritic cells (DC) paly a key role in the induction and chronicity of psoriasis by capturing the antigenes and activating the T cell repsonse. This activation requires their migration from the cutaneous sensitisation site to the lymph nodes. This migration requires an important intracellular metabolic activity, with a strong involvmenet of glucdic metabolism. This activity is linked with the systemic activity. This study aims to compare the migration and the phenotypic and metabolic caracteristics of blood and skin DCs in patients with or without psoriasis and with or without type 2 diabetes,

NCT ID: NCT05391178 Recruiting - Psoriasis Clinical Trials

Improving Disease Severity

Start date: August 9, 2022
Phase: N/A
Study type: Interventional

Phototherapy, including ultraviolet B (UVB) and ultraviolet A (UVA) light, has been used to treat a number of dermatologic conditions. Psoriasis is one of the most common conditions treated with phototherapy, in which phototherapy is often indicated for extensive disease with contraindications for other systemic treatments. The mechanism of action of phototherapy for the treatment of psoriasis is not completely understood; however, it is known that UVB light induces apoptosis of pathogenic T cells and keratinocytes, which may reduce the overactive immune response and epidermal hyperproliferation. Phototherapy has shown some efficacy for other diseases, such as alopecia areata (AA) and polymorphous light eruption (PMLE). However, phototherapy is not always an accessible treatment option for patients due to cost or lack of time.

NCT ID: NCT05390515 Recruiting - Psoriasis Vulgaris Clinical Trials

Psoriatic Immune Response to Tildrakizumab

Start date: September 1, 2022
Phase: Phase 4
Study type: Interventional

This study aims to assess cutaneous and blood immune cell function of patients with psoriasis before and after initiation of treatment with the IL23 blocker, tildrakizumab.

NCT ID: NCT05388916 Active, not recruiting - Clinical trials for Moderate to Severe Chronic Plaque Psoriasis

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

Start date: September 8, 2022
Phase:
Study type: Observational

This is a non-interventional, prospective, multi-center real world setting study, aiming to provide safety and effectiveness data in Chinese pediatric patients with moderate to severe plaque psoriasis treated with Cosentyx® for up to 52 weeks.

NCT ID: NCT05381402 Not yet recruiting - Clinical trials for The Impact of COVID19 on Psoriasis Patients

Impact of COVID 19 on Psoriasis Patients

Start date: May 20, 2022
Phase:
Study type: Observational

The main objective of this work is to investigate the effect of COVID-19 pandemic on psoriasis patients. This work is designed as a cross-sectional survey based on a questionnaire directed to Egyptian psoriasis patients.